Hosted on MSN
Alnylam Pharma announces convertible notes buyback
An announcement from Alnylam Pharma ( (ALNY)) is now available. On December 10, 2025, Alnylam Pharmaceuticals announced it had entered into privately negotiated repurchase agreements to buy back ...
In the realm of biotech and pharmaceuticals, fundraising often plays a pivotal role in driving innovation and progress. Biotech and pharmaceutical companies, whether private startups or established ...
The Notes will be guaranteed on a senior unsecured basis by Royalty Pharma Holdings Ltd. The offering is expected to close on June 10, 2024, subject to the satisfaction of customary closing conditions ...
GAITHERSBURG, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on ...
Hosted on MSN
Royalty Pharma plc (RPRX) Completes $2B Senior Notes Offering, Strengthens Capital for Growth
In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Royalty Pharma plc is one of them. Royalty Pharma plc (NASDAQ:RPRX), a leader in biopharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results